We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App





EUROMEDLAB 2022 Showcases Breakthrough Technologies and Cutting Edge Scientific Advances in Clinical Lab Diagnostics

By Carolyn Moody, RN - News Editor
Posted on 11 Apr 2022

The 24th European Congress of Clinical Chemistry and Laboratory Medicine (EUROMEDLAB 2022) saw exhibitors displaying innovations in clinical laboratory diagnostic technologies and offering attendees a hands-on experience with the latest instruments, machines and equipment. More...

The five-day event held from 10th-14th April 2022 in Munich, Germany brought together scientists, laboratory specialists, clinicians, and industry participants in the field of clinical chemistry and laboratory medicine. The show attracted more than 3,000 active participants from across the world, and a number of international speakers and key opinion leaders were invited to address front-edge topics in diagnostic technologies, health care and scientific advances. Among the attendees were private and hospital laboratories, biologists, technicians, biomedical engineers and students.

Following its biannual pattern, EUROMEDLAB had originally been scheduled to take place in late November 2021. However, due to the critical pandemic situation at the venue – Munich in Bavaria, Germany – at that time, the congress was postponed to 10th-14th April 2022, prioritizing the health and safety of all visitors and exhibitors over other aspects. The congress was a hybrid event, with selected symposia and the opening and closing ceremony also held virtually. All COVID-19 restrictions to enter the Congress Centre had been cancelled, allowing all participants and visitors to freely access the Congress Centre and visit EUROMEDLAB. The importance of the live experience was reflected in the impressive reservation numbers. The floorspace of the 10,000-m2 Hall C1 and the ICM foyer was completely sold out and the number of research projects increased as compared to EUROMEDLAB 2020 with a total of 900 scientists submitting their abstracts as compared to 720 for the previous event. As such, the congress continued to grow in importance as a European hotspot for the science industry.

During the congress, attendees were able to experience the outstanding scientific program, which featured innovative and diverse educational opportunities that incorporated the best of clinical laboratory medicine and in vitro diagnostics, including lectures, symposia, recent advancements in clinical practice and science, poster presentations, and much more. A broad range of international speakers, key opinion leaders and stakeholders brought front-edge topics in health care, diagnostic technologies, scientific advances and professional matters to life. Special emphasis was placed on technological advancements, as the meeting aimed to connect the latest technological breakthroughs in diagnostic laboratory technology with the best minds in laboratory medicine to help attendees learn and implement the latest and greatest in clinical laboratory science, technology, and medicine. Attendees were also able to access a lively industry exhibition floor featuring the latest products and developments in diagnostic technologies brought by leading manufacturers. For those who were unable to able to attend the event in person, the show offered a brand-new format of interacting virtually with companies during the conference through the “Exhibition Floor Walks.”


Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
Online QC Software
Acusera 24•7
New
Gold Member
Pre- Eclampsia Control
Acusera Pre-Eclampsia Control
New
Blood-Based Protein Biomarker Solution for Alzheimer's Disease
BG-DTi2000.
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The approach supports myocardial infarction diagnosis in resource-limited settings by reducing delays between clinical suspicion and biochemical confirmation (Image Credit: Adobe Stock)

Portable Troponin Assay Brings Heart Attack Diagnosis Closer to Patients

Timely confirmation of myocardial infarction often depends on laboratory testing that may not be immediately available at the point of care. This gap between clinical suspicion and definitive evidence... Read more

Molecular Diagnostics

view channel
Image: The two new tests are used with the LightCycler 480 and LightCycler PRO instruments (Photo courtesy of Roche)

New PCR Assays Expand Cyclospora Testing for Outbreak Surveillance

Cyclospora cayetanensis, a food- and waterborne intestinal parasite, can cause prolonged diarrhea, fatigue, and abdominal cramping, placing added strain on urgent care and emergency departments during outbreaks.... Read more

Immunology

view channel
Image: Graphical Abstract (Morgane Fournier et al., Cell (2026). DOI: 10.1016/j.cell.2026.04.013)

Study Reveals Immune Mechanism Driving Severe COVID-19 Progression

Severe COVID-19 has highlighted gaps in understanding of early antiviral responses, particularly why some patients deteriorate despite timely care. Type I interferons are central to host defense, yet their... Read more

Microbiology

view channel
Image: An innovative countywide program in Taiwan combines risk-based screening with decentralized community care to improve hepatitis C detection and treatment (Image Credit: iStock)

Precision Screening Helps Close Hepatitis C Diagnosis and Treatment Gaps

Hepatitis C remains a leading cause of cirrhosis and liver cancer, yet many infections go undiagnosed or untreated because health systems fail to reach those at greatest risk. Although highly effective... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.